TransMedics (TMDX) EBIT Growth (1y) (2019 - 2026)
TransMedics (TMDX) EBIT Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 16.18% |
| 10 | TransMedics | 3.18 Bn | 2.71 Bn | 113.20 Mn | -35.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.09% |
| Mar 31, 2026 | -51.55% |
| Dec 31, 2025 | 146.10% |
| Sep 30, 2025 | 493.93% |
| Jun 30, 2025 | 192.35% |
| Mar 31, 2025 | 120.94% |
| Dec 31, 2024 | 232.08% |
| Sep 30, 2024 | 113.85% |
| Jun 30, 2024 | 1,480.57% |
| Mar 31, 2024 | 694.59% |
| Dec 31, 2023 | 138.40% |
| Sep 30, 2023 | -411.09% |
| Jun 30, 2023 | 90.70% |
| Mar 31, 2023 | 77.70% |
| Dec 31, 2022 | 40.16% |
| Sep 30, 2022 | 52.72% |
| Jun 30, 2022 | 1.25% |
| Mar 31, 2022 | -43.98% |
| Dec 31, 2021 | -92.13% |
| Sep 30, 2021 | -154.34% |